Why more companies are fighting over consumers' beauty, health and wellness spending

1 day ago

Mitch McConnell returns to Senate after three-month health absence

5 days ago

Athletes with autism take center court at the US Open

5 days ago

Novo CEO tells CNBC why drugmaker is rebranding, needs to 'rethink' strategy

5 days ago

Record U.S. cyclosporiasis outbreak is over, CDC says

8 days ago

A rapid-fire update on our 33-stock portfolio, including 6 stocks to buy now

8 days ago

Rare disease is taking his vision. A gene therapy could help — if he can get it

9 days ago

Jim Cramer says investors are too focused on AI stocks. Here's where he says to look instead

11 days ago

'Patients pay the tariff': Swiss pharma CEO warns of Trump's generic drug tariff threat

11 days ago

AstraZeneca's COPD drug shows late-stage trial wins, boosts blockbuster hopes

11 days ago

Pharma major Novartis falls 10% after three drug trial setbacks

11 days ago

Cholesterol drug setback casts doubt over multibillion-dollar race

12 days ago

Billionaire family offices back healthcare and biotech startups in August

16 days ago

Cramer: Here are 3 defensive stock market moves I'm making as oil and rates surge

18 days ago

We're adding 2 stocks to our Bullpen watchlist because they meet these criteria

18 days ago

This medical device stock looks like a gift for patient investors

18 days ago

August was the month of the comeback kids. Cramer reviews what drove the biggest winners

19 days ago

Trump strikes new drug pricing deals with nine midsized drugmakers

19 days ago

BioCryst is profitable. Now it wants to buy more rare disease drugs

22 days ago

How Taylor Farms became integral to America's food supply system

22 days ago

FDA approves daily HIV pill from Gilead designed to simplify treatment

22 days ago

HHS plans new FDA leadership roles for technology and drugs, sources say

23 days ago

Why vaccination rates are falling in the U.S.

25 days ago

BioMarin to acquire Alesta Therapeutics for $275 million

29 days ago

Cancer vaccine from Moderna, Merck shows promise in late-stage trial; both stocks soar

1 month ago

Hims & Hers CEO says FTC lawsuit misunderstands how the company works

1 month ago

The startup using AI to help rare disease families develop custom treatments

1 month ago

Court rules companies can't import Gilead medications from overseas

1 month ago

Novo Nordisk CEO defends lawsuit against Eli Lilly: 'Competition has to be fair'

1 month ago

Trump administration ends Medicaid, CHIP funding for gender-affirming care for children

1 month ago

We're lifting our price target on Cardinal Health after issuing rosy profit guidance

1 month ago

Trump wants to split the MMR vaccine. Experts say that's unlikely

1 month ago